Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Share-based Compensation (2018 - 2021)

Acro Biomedical (ACBM) has 3 years of Share-based Compensation data on record, last reported at $3.9 million in Q4 2021.

  • For Q4 2021, Share-based Compensation changed N/A year-over-year to $3.9 million; the TTM value through Dec 2021 reached $6.8 million, up 2206.94%, while the annual FY2021 figure was $7.7 million, N/A changed from the prior year.
  • Share-based Compensation reached $3.9 million in Q4 2021 per ACBM's latest filing, up from $2.9 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $3.9 million in Q4 2021 and bottomed at $148395.0 in Q1 2019.
  • Average Share-based Compensation over 3 years is $1.2 million, with a median of $150044.5 recorded in 2018.